ONLY $9.90 DELIVERY INFO

Close Notification

Your cart does not contain any items

The Thriving Biopharma Business

How to Unlock Value and Drive Success in Biotech and Pharma

Alain Eudaric Jean-Noël Pellegrin

$123.95   $99.47

Paperback

Forthcoming
Pre-Order now

QTY:

English
Routledge
31 October 2025
In today’s fiercely innovative and complex biopharmaceutical industry, successfully managing a pharmaceutical or biotech company from concept to patients requires exceptional strategic, leadership, and managerial abilities. This book is a definitive reference that uniquely integrates critical business, strategy, finance, M&A, regulatory, and intellectual property concepts.

Bringing new therapies to market is both a sought-after experience and a distinguished accomplishment. A biopharma leadership team that is able to master the critical levers covered in this book will drive unparalleled value creation through tremendous competitive advantage in the industry. Chapter by chapter, you'll delve into innovation, valuation, intellectual property, strategy, financing, pitching, transactions, contracts, and regulatory affairs. Through numerous case examples and concepts, you’ll learn practical avenues to avoid pitfalls, drive value creation, and navigate the intricate world of the biopharma industry.

This book equips decision-makers, founders, investors, and industry professionals with frameworks, illustrations, and actionable ideas, enabling them to tackle the strategic and managerial challenges inherent in the evolution of a biopharma company. Elevate your strategic decisions, unlock new opportunities, and lead your company to success with this indispensable resource.
By:   ,
Imprint:   Routledge
Country of Publication:   United Kingdom
Dimensions:   Height: 229mm,  Width: 152mm, 
Weight:   453g
ISBN:   9781032976211
ISBN 10:   1032976217
Pages:   436
Publication Date:  
Audience:   College/higher education ,  Professional and scholarly ,  Adult education ,  Primary ,  Undergraduate
Format:   Paperback
Publisher's Status:   Forthcoming
Preface Acknowledgments Chapter 1 Setting the Stage for Biopharma Innovation Chapter 2 The Basic Valuation Toolkit Chapter 3 The Rigors and Importance of Intellectual Property Chapter 4 Strategy for Biopharma Companies Chapter 5 Company Financing Chapter 6 Pitching Your Company Chapter 7 Understanding the Art of the Deal in Biopharma Chapter 8 Contractual Considerations for Biopharma Deals Chapter 9 Essential Regulatory Notions Index

Alain Eudaric brings over 30 years of global expertise in biopharma, life sciences, and consulting, specializing in strategy, M&A, alliances, and innovation-led growth. He has held leadership roles at Kearney, Thermo Fisher Scientific, and Parexel International, driving transformative programs and business success. As President of Idea Pathways, Alain focuses on driving operational excellence and fostering innovative growth strategies for the biopharma industry. He is an alum from Harvard Medical School, Johns Hopkins University, MIT, Purdue University, and Ecole Centrale de Lille with advanced degrees in Biotech, Business, Science, and Engineering. Jean-Noël Pellegrin has over 15 years of expertise in M&A and business development, with a proven track record of contributing to several hundred successful transactions. He began his career at EY before most recently joining Sanofi, where he has spent the last 20 years in France and the United States. His 30 years of combined experience across global public company financa, audit, accounting, and strategic transactions make him a trusted expert in valuing life sciences assets and structuring complex deals. He is an alum of Babson College and Sciences Po, with advanced degrees in Business and Finance.

Reviews for The Thriving Biopharma Business: How to Unlock Value and Drive Success in Biotech and Pharma

""A practical, straight-to-the-point guide for biotech leaders. It covers everything from valuation to partnerships—knowledge you don’t learn in a lab."" Adrien Châtillon, CEO and Serial Entrepreneur in Neuroscience ""Congratulations on this book — a rare and insightful work that demystifies business development / mergers & acquisitions in biopharma."" Loïc Gonnet, Global Head of Mergers & Acquisitions at Sanofi ""A well-rounded and insightful book that covers key aspects of the biopharma industry. A great resource for both experienced professionals and those just starting out."" Naji Gehchan, MD, MBA, Chief Medical & Development Officer I, Former Head of Global Development at Eli Lilly


See Also